Contact Us
100 Cummings Center, Suite 407-P, Beverly, Massachusetts 01915, USA
+1 (978) 720-8044
Contact Us
100 Cummings Center, Suite 407-P, Beverly, Massachusetts 01915, USA
+1 (978) 720-8044
Thrive Bioscience, established in 2014 in Boston, is more than just a company – it's a mission. We provide cutting-edge instruments and software for automated live cell imaging and analytics. The company has three products in the market. With the backing of experienced industry professionals and investors, Thrive Bioscience holds a significant portfolio of patents covering a wide range of innovations. Our mission is to tackle the reproducibility crisis in biomedical research and accelerate successful drug discovery. We invite you to join us in this critical endeavor.
The CellAssist family of instruments and software provides researchers with automated imaging, smart analytics, and documentation for reproducible cell biology. For live cell biology, CellAssist Systems consistently captures the large quantities of data needed at more than 100 focal planes precisely over time, combined with extensive documentation. Thrive Bioscience’s products enable significantly improved cell culture processes, improved cell-based experiments, and breakthrough insights.
Learn More About CellAssist
As the life sciences industry continues to expand, the demand for advanced, automated solutions that improve the efficiency and reliability of research will only grow. Thrive Bioscience's CellAssist family is well-equipped to provide solutions, positioning the company for significant growth. Thrive Bioscience is transforming the landscape of cell culture and driving faster, more effective drug discovery.
As the life sciences industry continues to expand, the demand for advanced, automated solutions that improve the efficiency and reliability of research will only grow. Thrive Bioscience's CellAssist family is well-equipped to provide solutions, positioning the company for significant growth. Thrive Bioscience is transforming the landscape of cell culture and driving faster, more effective drug discovery.
Thrive Bioscience has raised a substantial $45 million from family offices, angel groups, industry veterans, and venture capital firms. This strategic investment is a testament to our potential and will be used to fund the development and commercialization of our first automated live cell imaging instruments and software, ensuring our financial stability and growth.
If you are an investor interested in learning more about Thrive Bioscience, please do not hesitate to contact us. We look forward to discussing how you can be part of our journey.
